login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
More Than a Million Britons Will Suffer from Dementia by 2028: Experts
According to experts, the number of patients diagnosed with diseases such as Alzheimer's will increase by 70 per cent to more than 1.2 million by 2028.
According to psychiatrists and charities, not enough is being spent on research, treatment and care, which is possibly leading to the rise of the disease.
The report by the Department of Health's Horizon Scanning Unit Drugs also showed that drugs such as Aricept, which slow the appearance of the symptoms of Alzheimer's, are restricted by the NHS because they cost 2.50 pounds a day, despite being widely available in other countries.
The research revealed that the number of people aged over 85 would have doubled by 2028. One in four will develop dementia.
The number between 65 and 74 will also increase by 40 per cent and those aged 75 to 84 will rise by 50 per cent.
According to the Alzheimer's Society charity, the document's findings would mean an extra 500,000 people living with dementia.
There are 700,000 at present. The cost of long-term care for dementia patients will more than triple to 17 billion pounds.
Prof David Wilkinson, a psychiatric consultant of Southampton University, described the figures as staggering and called for urgent action to increase funding and research for Alzheimer's, the most common cause of dementia.
|
|
|
More News on: Alzheimers Disease, Geriatry-Related Diseases
 Comment & Contribute
|
Medwonders Health Network
- Health News Index
|
|
- News Quick Links
| News Categories: |
| » | Prednisolone Benefits Patients With Bell's Palsy |
| » | 'Orphan' Sleep Drug may Fight Cancer |
| » | New Drugs for Fox Tapeworm Infection |
| » | Poor Quality Antimalarial Drugs Pose Threat |
| » | New Drug Shows Promise Against Localized High-risk Prostate Tumors |
| More Drug News | |
|
